12:44:45 PM PDT - Saturday, July 20th, 2019

Purdue Continued Pitching OxyContin Despite Concerns Raised By Sales Reps, New Suit From Pennsylvania Alleges  

By Editor - Wed May 15, 9:09 am

  • Comments Off on Purdue Continued Pitching OxyContin Despite Concerns Raised By Sales Reps, New Suit From Pennsylvania Alleges

The suit says Purdue Pharma drug representatives made 531,000 calls on doctors in the state since 2007, when the company settled with Pennsylvania and 25 other states and agreed to stop illegal diversion of OxyContin and to promote it only for federally approved uses. The company is facing a barrage of legal challenges from local counties, states and other parties eager to hold it accountable for the role it played in the opioid epidemic.

Originally posted here:

Purdue Continued Pitching OxyContin Despite Concerns Raised By Sales Reps, New Suit From Pennsylvania Alleges

  • Comments Off on Purdue Continued Pitching OxyContin Despite Concerns Raised By Sales Reps, New Suit From Pennsylvania Alleges

Leave a Reply

Comments are closed on this post.